Literature DB >> 28471864

Mycoplasma Pneumoniae: A Cross-sectional Population-based Comparison of Disease Severity in Preschool and School-age Children.

Christopher Stephen Inchley1, Are Stuwitz Berg, Afsaneh Vahdani Benam, Anne Katrine Kvissel, Truls Michael Leegaard, Britt Nakstad.   

Abstract

BACKGROUND: Mycoplasma pneumoniae causes epidemics of upper respiratory disease and pneumonia. It is thought that M. pneumoniae usually causes milder upper respiratory disease in preschool children, with a greater chance of pneumonia in school-age children. In this population-based cross-sectional study, we present evidence that severe M. pneumoniae infection is more common in preschool children than previously thought.
METHODS: During an M. pneumoniae epidemic in our area, widespread health service and public awareness lead to extensive testing for M. pneumoniae. Medical records of hospital-referred M. pneumoniae-positive children were assessed retrospectively for respiratory disease and chest radiographic results. Severe disease was defined as supplementary oxygen or fluid requirement, mechanical ventilatory support or neurologic disease. Age-specific population figures were used to calculate incidence during the study period. Those who were 0-5-year-olds were considered preschool, whereas 6-17-year-olds were considered school-aged.
RESULTS: Thirty-seven preschool and 55 school-age children were referred to the hospital and tested positive for M. pneumoniae. Twenty-two (60%) preschool and 23 (42%) school-age children had severe disease [incidence 56 vs. 29 per 100,000; relative risk: 1.9; 95% confidence interval (CI): 1.06-3.4; P = 0.03]. Twenty (54%) preschool and 19 (35%) school-age children had severe pneumonia (incidence 51 vs. 24 per 100,000; relative risk: 2.1; 95% CI: 1.1-3.9; P = 0.03).
CONCLUSIONS: During an M. pneumoniae epidemic in Akershus and North Oslo in 2011-2012, preschool children infected with M. pneumoniae had significantly higher risk of severe disease, particularly severe pneumonia, when compared with school-age children. M. pneumoniae should be considered a potential pathogen in younger children with respiratory distress, particularly during an epidemic period.

Entities:  

Mesh:

Year:  2017        PMID: 28471864     DOI: 10.1097/INF.0000000000001628

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

1.  Serological diagnosis of Mycoplasma pneumoniae infection by using the mimic epitopes.

Authors:  Wenyuan Shi; Lanhua Zhao; Shengtao Li; Guizhen Xu; Yanhua Zeng
Journal:  World J Microbiol Biotechnol       Date:  2018-05-29       Impact factor: 3.312

2.  Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study.

Authors:  Yiping Zhou; Yijun Shan; Yun Cui; Jingyi Shi; Fei Wang; Huijie Miao; Chunxia Wang; Yucai Zhang
Journal:  Crit Care Explor       Date:  2021-03-23

3.  Clinical manifestations in infants and children with Mycoplasma pneumoniae infection.

Authors:  Mia Johanna Søndergaard; Martin Barfred Friis; Dennis Schrøder Hansen; Inger Merete Jørgensen
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

4.  Pulmonary and Extrapulmonary Manifestations in Hospitalized Children with Mycoplasma Pneumoniae Infection.

Authors:  Carlotta Biagi; Alessandra Cavallo; Alessandro Rocca; Luca Pierantoni; Davide Antonazzo; Arianna Dondi; Liliana Gabrielli; Tiziana Lazzarotto; Marcello Lanari
Journal:  Microorganisms       Date:  2021-12-10

5.  Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Tongqiang Zhang; Chunjiao Han; Wei Guo; Jing Ning; Chunquan Cai; Yongsheng Xu
Journal:  Front Pediatr       Date:  2021-12-09       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.